Quick navigation menu :

  1. Go to content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the help menu
  5. Go to the modules
  6. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
     
  2. Global Business Websites |
     
  3. Contact Us |
  4. Sitemap |
  5. Help
  1. Font size

    Reduce Increase  
 
 

Your Health

Contact Us

sanofi-aventis Pakistan limited

Registered Office

Plot 23, Sector 22
Korangi Industrial Area
Karachi-74900

Postal Address

P.O. Box 4962
Karachi-74000

Tel: +92-21-35060221-35

Content :

Thrombosis

Venous Thromboembolism (VTE), which is the obstruction of a vein by a blood clot, is the third most common cardiovascular disease in the western world, occurring in about 0.1% of people every year.

 

Venous and arterial thrombosis

Thrombosis occurs when a thrombus or blood clot is formed in a blood vessel (vein or artery).
Without treatment, the thrombus may become Enlarged to the point where it occludes the vessel and prevents blood and oxygen from irrigating the organ concerned.
Deep venous thrombosis (DVT) occurs when a blood clot develops in the deep veins of the leg. There is a risk that the clot may be detached from the vascular wall, migrate towards the heart and penetrate the lungs (pulmonary embolism). Acute coronary syndromes are the result of blood clots forming in the arteries so that the heart’s supply of oxygen is reduced.

Thrombosis

4 million patients worldwide

Every year, over 4 millions patients worldwide are affected by DVT.Arterial thrombosis is the cause of over 600,000 deaths per year.

Targeted disorders

  • Deep venous thrombosis with or without pulmonary embolism
  • Arterial thrombosis
  • Acute coronary syndrome (unstable angina, myocardial Infarction)
  • Thromboembolic diseases

Updated September 02, 2014

Module :

Thrombosis